Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/08/2014US8771726 Nail patch
07/08/2014US8771725 Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same
07/08/2014US8771716 Modified release analgesic suspensions
07/08/2014US8771712 Topical administration of acyclovir
07/08/2014US8771701 Compositions for immunotherapy and uses thereof
07/08/2014US8771691 Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma
07/08/2014US8771681 Methods and compositions for protecting and treating muscarinic receptors by administering a pyrophosphate analog to a subject exposed to bacterial, fungal, viral, prion or algal infection
07/08/2014US8771662 Multi-arm polymer prodrugs
07/08/2014US8771648 (Trimethoxyphenylamino) pyrimidinyl formulations
07/08/2014US8771641 Aryloxyanilide imaging agents
07/08/2014US8770201 Condom with multifunctional coating
07/08/2014CA2819705C Method of regulating glucose metabolism, and reagents related thereto
07/08/2014CA2771951C Compositions and methods for bone formation and remodeling
07/08/2014CA2763960C Bicyclic and tricyclic compounds as kat ii inhibitors
07/08/2014CA2763384C Use of a composition of a mixture of galactooligosaccharides for preventing diarrhoea
07/08/2014CA2762340C Compositions and methods for treating joints
07/08/2014CA2762013C Granulation of pirfenidone and pharmaceutically acceptable excipients
07/08/2014CA2747419C Sulfonamide derivatives
07/08/2014CA2746427C Phenylpyrimidone compounds, the pharmaceutical compositions, preparation methods and uses thereof
07/08/2014CA2742007C Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
07/08/2014CA2738384C Pharmaceutical topical compositions
07/08/2014CA2737879C Single unit carbapenem aminoglycoside formulations
07/08/2014CA2735478C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
07/08/2014CA2711611C Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
07/08/2014CA2685216C Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
07/08/2014CA2682391C (aza)indole derivative and use thereof for medical purposes
07/08/2014CA2680647C Preparations of taxanes for intravenous administration and the preparation method thereof
07/08/2014CA2678367C Sustained release compositions using wax-like materials
07/08/2014CA2676300C Cellulose derivative and method for production thereof
07/08/2014CA2671699C Thienyl-containing glycopyranosyl derivatives as antidiabetics
07/08/2014CA2660707C Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
07/08/2014CA2656264C Method for producing crystal polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid
07/08/2014CA2652501C Novel heterocyclic compound or salt thereof and intermediate thereof
07/08/2014CA2652220C Adhesive preparation comprising methyl salicylate for percutaneous absorption
07/08/2014CA2650926C N1,n4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and methods thereof
07/08/2014CA2650553C 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
07/08/2014CA2650341C Augmentation of titer for vaccination in animals
07/08/2014CA2650009C Il-8 receptor antagonists
07/08/2014CA2648003C Orally bioavailable caffeic acid related anticancer drugs
07/08/2014CA2647986C Compositions for tumor growth control
07/08/2014CA2638095C New compounds
07/08/2014CA2635850C Heterocyclic janus kinase 3 inhibitors
07/08/2014CA2632217C Pyridiazinone derivatives for the treatment of tumours
07/08/2014CA2629530C N-substituted indenoisoquinolines and syntheses thereof
07/08/2014CA2625871C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/08/2014CA2624524C Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
07/08/2014CA2624504C Benzimidazolone compounds which have activity at m1 receptor and their uses in medicine
07/08/2014CA2624141C Quinazoline derivative and pharmaceutical
07/08/2014CA2623965C 5h-thieno (3,4-c) pyrrole-4, 6-dione derivatives against cell releasing tumor necrosis factor
07/08/2014CA2617188C Antimicrobial and/or antiviral composition and to methods for preparing and administering same
07/08/2014CA2617107C Olanzapine analogs and methods of use thereof
07/08/2014CA2613434C Method and composition for treating osteoarthritis
07/08/2014CA2604052C Methods and compositions for the treatment of cns-related conditions
07/08/2014CA2600331C Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases
07/08/2014CA2599304C Cell targeting conjugates
07/08/2014CA2597982C Boron-containing small molecules
07/08/2014CA2596736C Tricyclic cytoprotective compounds
07/08/2014CA2596210C Combination therapies using hdac inhibitors
07/08/2014CA2595295C Protease inhibitor precursor synthesis
07/08/2014CA2590277C Product containing prostaglandin having fluorine atom in its molecule
07/08/2014CA2589828C Compositions comprising a taxoid and a benzimidazole carbamate for the treatment of cancer
07/08/2014CA2589261C Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
07/08/2014CA2584547C Solid pharmaceutical composition comprising donepezil hydrochloride
07/08/2014CA2580707C Rnai modulation of apob and uses thereof
07/08/2014CA2579338C A topical medicament comprising menthol,camphor,potassium, and a source of oxygen
07/08/2014CA2568213C Composition and method for the treatment of tauopathies
07/08/2014CA2566874C Targeted delivery of anti-viral compounds through hemoglobin bioconjugation
07/08/2014CA2565182C Intravitreal implants comprising microspheres which encapsulate a tyrosine kinase inhibitor and a biodegradable polymer
07/08/2014CA2558465C Fat metabolism improving agent
07/08/2014CA2554633C Galenic formulations of organic compounds
07/08/2014CA2544050C Use of plant parts of prickly pear (opuntia) and/or extracts therefrom for the treatment of depressions
07/08/2014CA2524891C Ultraviolet-shielding type patch
07/08/2014CA2523083C Antiviral phosphonate analogs
07/08/2014CA2520255C Tie-2 modulators and methods of use
07/08/2014CA2517002C Methods of making 6-[(4,5-dihydro-1h-imidazol-2-yl)amino-]-7-methyl-1h-benzimidazole-4-carbonitrile and its preferred salt form
07/08/2014CA2512582C Antibacterial agents
07/08/2014CA2507450C Use of a histone deacetylase inhibitor for treating muscular dystrophies
07/08/2014CA2497195C Methods and compositions for controlled release of drugs
07/08/2014CA2493753C Immunostimulatory nucleic acids
07/08/2014CA2482705C Use of meglumine for inhibiting 3-deoxyglucosone synthesis in the skin
07/08/2014CA2472633C S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
07/08/2014CA2469370C Adipose-derived cell processing unit
07/08/2014CA2463816C Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
07/08/2014CA2417568C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
07/08/2014CA2415422C Chromosome 3p21.3 genes are tumor suppressors
07/08/2014CA2350395C Nucleotide and protein sequences of nogo genes and methods based thereon
07/08/2014CA2333087C Compositions and methods for the pulmonary delivery of nucleic acids
07/03/2014WO2014106238A1 Heterocyclic compounds and methods of use thereof
07/03/2014WO2014106194A1 Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof
07/03/2014WO2014106165A1 System and method for analysis of bio-metabolites for-use in image-guided surgery
07/03/2014WO2014106126A1 Scalp and/or hair treatment compositions and combinations
07/03/2014WO2014106091A1 Solution for preserving vascular conduits
07/03/2014WO2014106021A1 Treatment of rhinosinusitis with p-glycoprotein inhibitors
07/03/2014WO2014106019A2 Novel antiviral agents against hbv infection
07/03/2014WO2014106016A1 Multi-polymer compositions for transdermal drug delivery
07/03/2014WO2014106014A1 Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
07/03/2014WO2014106009A1 Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents
07/03/2014WO2014105966A2 Ddr2 mutations as targetable features of melanoma or basal cell carcinoma
07/03/2014WO2014105957A1 Indole compounds for use in treating inflammation and cancer
07/03/2014WO2014105926A1 Novel betulinic acid proline derivatives as hiv inhibitors
1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 7860